Market potential

Cancer represents the fastest growing pharmaceutical market

The strong growth in sales of cancer therapeutics witnessed within the past few years is primarily due to the launch of a number of new and specific anti-cancer drugs. In 2006, the global expenditure for oncology drugs was USD 44 billion, up from USD 12 billion in 2000 and the expenditure is expected to increase to USD 65 billion by 2010 and USD 72 billion in 2012.

In the years ahead a continuing trend towards more targeted cancer therapies is expected. Additionally, a large number of more biologically specific cancer products will reach the market, further expanding the market for cancer therapeutics. TopoTarget considers itself a key player in the cancer therapeutics market and expects to make a substantial contribution to the development of more effective anti-cancer drugs.